EGFR and neoplasm: In a parallel screen, we started with neoplastic tumors produced by co-expression of UAS-EGFR and UAS-SOCS36ERNAi [Herranz et al. 2012] and asked whether including expression of another RNAi transgene could suppress neoplasia (Figure 1A, right panels).